Fadi Al Shatarat
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Fadi Al Shatarat has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Constantin Osman
Grigore T. Popa University of Medicine and Pharmacy, 700115 Iasi, Romania
1 shared publication - Emanuel Baltig
Department of Radiotherapy, Regional Institute of Oncology (IRO), 700483 Iasi, Romania
1 shared publication - Gabriel Mihail Dimofte
Grigore T Popa University of Medicine and Pharmacy, 700115 Iasi, Romania
1 shared publication - Mara Răzniceanu
Department of Surgery, Grigore T Popa University of Medicine and Pharmacy, 700115 Iasi, Romania
1 shared publication - Monica Buzemurga
Department of Radiotherapy, Regional Institute of Oncology (IRO), 700483 Iasi, Romania
1 shared publication - Raluca Zaharia
Grigore T Popa University of Medicine and Pharmacy, 700115 Iasi, Romania
1 shared publication
Latest Publications
- Open Access
- 19 April 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (8) , 2831
Predictive Risk Factors for Low Anterior Resection Syndrome (LARS) in Rectal Cancer—An Observational Cohort Study
Background/Objectives: The improved long-term survival of rectal cancer patients has led to a major increase in the prevalence of functional complications. Understanding which patients are prone to develop major LARS is important for their preoperative counselling and follow-up. Herein, we aimed to assess the risk factors for LARS. Methods: This is a retrospective cohort study on rectal cancer patients. All patient and tumour variables, management plan, type of neoadjuvant therapy, radiation dose to anal sphincter, and perioperative outcomes were collected from the hospital electronic databases. We quantified LARS and compared the score before and after surgery (mean follow-up of 42.2 ± 32 months). Results: A total of 182 patients were included for the final analysis. LARS was present in 43.4% (n = 79) of patients, with 14.8% (n = 27) having minor LARS and 28.5% (n = 52) having major LARS. Age (p = 0.03), male gender (p < 0.00001), smoking (p = 0.04), neoadjuvant radiotherapy (p = 0.02), rectal stump length (p = 0.008), end-to-end anastomosis (p = 0.008), and ileostomy (p = 0.002) were found to significantly increase the rate of LARS. A logistic regression model based on the above variables was able to predict major LARS with good predictive value (AUC 0.700). Conclusions: LARS is highly common after sphincter-preserving surgery, and it is significantly more common in young, male patients with a history of smoking, having mid-lower rectal cancers with neoadjuvant radiotherapy, and undergoing TME surgery with end-to-end low anastomosis and ileostomy.
- 19 April 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (8) , 2831
Open AccessPredictive Risk Factors for Low Anterior Resection Syndrome (LARS) in Rectal Cancer—An Observational Cohort Study
Background/Objectives: The improved long-term survival of rectal cancer patients has led to a major increase in the prevalence of functional complications. Understanding which patients are prone to develop major LARS is important for their preoperative counselling and follow-up. Herein, we aimed to assess the risk factors for LARS. Methods: This is a retrospective cohort study on rectal cancer patients. All patient and tumour variables, management plan, type of neoadjuvant therapy, radiation dose to anal sphincter, and perioperative outcomes were collected from the hospital electronic databases. We quantified LARS and compared the score before and after surgery (mean follow-up of 42.2 ± 32 months). Results: A total of 182 patients were included for the final analysis. LARS was present in 43.4% (n = 79) of patients, with 14.8% (n = 27) having minor LARS and 28.5% (n = 52) having major LARS. Age (p = 0.03), male gender (p < 0.00001), smoking (p = 0.04), neoadjuvant radiotherapy (p = 0.02), rectal stump length (p = 0.008), end-to-end anastomosis (p = 0.008), and ileostomy (p = 0.002) were found to significantly increase the rate of LARS. A logistic regression model based on the above variables was able to predict major LARS with good predictive value (AUC 0.700). Conclusions: LARS is highly common after sphincter-preserving surgery, and it is significantly more common in young, male patients with a history of smoking, having mid-lower rectal cancers with neoadjuvant radiotherapy, and undergoing TME surgery with end-to-end low anastomosis and ileostomy.